Emory University Buys argenx SE, Athenex Inc, Arena Pharmaceuticals Inc, Sells Alnylam Pharmaceuticals Inc, Acceleron Pharma Inc, Dicerna Pharmaceuticals Inc

• New Purchases: ARGX, ATNX, ARNA, ACA,
• Added Positions: SLDB, RTRX, ADS, NBIX, CRNX, WVE, MS, AMRN, BMRN, MDGL, HRTX, C, BHC, SPY,
• Reduced Positions: GBT, RARX, INCY, SGEN, BCRX, ASND, IFRX, ACAD, ZGNX, MYOV, CBRE, IOVA, TRN, ALXN, GHDX, RYTM, FOLD, KKR, SLM, STX,
• Sold Out: ALNY, XLRN, DRNA, IMMU, AWI, LJPC, AMZN,

For the details of EMORY UNIVERSITY's stock buys and sells, go to https://www.gurufocus.com/guru/emory+university/current-portfolio/portfolio

1. Berkshire Hathaway Inc (BRK.A) - 117 shares, 25.72% of the total portfolio.
2. JD.com Inc (JD) - 397,528 shares, 8.75% of the total portfolio. Shares reduced by 0.01%
3. Ascendis Pharma A/S (ASND) - 32,477 shares, 2.79% of the total portfolio. Shares reduced by 17.19%
4. Amicus Therapeutics Inc (FOLD) - 208,854 shares, 2.07% of the total portfolio. Shares reduced by 4.14%
5. Amarin Corp PLC (AMRN) - 135,058 shares, 2.05% of the total portfolio. Shares added by 4.38%

Emory University initiated holding in argenx SE. The purchase prices were between $96.07 and $134.59, with an estimated average price of $117.13. The stock is now traded at around $120.00. The impact to a portfolio due to this purchase was 1.71%. The holding were 18,819 shares as of .

Emory University initiated holding in Athenex Inc. The purchase prices were between $11.11 and $13.49, with an estimated average price of $12.2. The stock is now traded at around $13.01. The impact to a portfolio due to this purchase was 1.69%. The holding were 188,696 shares as of .

Emory University initiated holding in Arena Pharmaceuticals Inc. The purchase prices were between $38.95 and $50.93, with an estimated average price of $45.78. The stock is now traded at around $51.24. The impact to a portfolio due to this purchase was 1.56%. The holding were 47,779 shares as of .

Emory University initiated holding in Arcosa Inc. The purchase prices were between $27.69 and $34.88, with an estimated average price of $30.5. The stock is now traded at around $36.06. The impact to a portfolio due to this purchase was 1.37%. The holding were 61,342 shares as of .

Emory University added to a holding in Solid Biosciences Inc by 334.97%. The purchase prices were between $7.19 and $32.37, with an estimated average price of $16.87. The stock is now traded at around $9.72. The impact to a portfolio due to this purchase was 1.55%. The holding were 298,887 shares as of .

Emory University sold out a holding in Alnylam Pharmaceuticals Inc. The sale prices were between $72.76 and $93.45, with an estimated average price of $83.46.

Emory University sold out a holding in Acceleron Pharma Inc. The sale prices were between $39.06 and $48.05, with an estimated average price of $43.83.

Emory University sold out a holding in Dicerna Pharmaceuticals Inc. The sale prices were between $9.74 and $14.65, with an estimated average price of $11.47.

Emory University sold out a holding in Immunomedics Inc. The sale prices were between $13.12 and $19.21, with an estimated average price of $16.02.

Emory University sold out a holding in Armstrong World Industries Inc. The sale prices were between $58.21 and $79.42, with an estimated average price of $69.44.

Emory University sold out a holding in La Jolla Pharmaceutical Co. The sale prices were between $5.24 and $10.52, with an estimated average price of $6.55.